Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Source filing unavailable
Q2 2013 · —
Revenue$2.24B$2.24B+2.3% vs Q2 2012 Net Income$28.87M$28.87M−4.1% vs Q2 2012 EPS Diluted$0.46$0.46−4.2% vs Q2 2012 Gross Profit$273,431,000+29.3% Operating Income$50,050,000−5.9% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
$24,568,000
−39.9%
Free Cash Flowderived$15,860,000−60.3% Margins · derivedGross margin12.2%+2.6 pt vs Q2 2012
Operating margin2.2%−0.2 pt vs Q2 2012
Net margin1.3%−0.1 pt vs Q2 2012